Concourse Financial Group Securities, Inc. Sangamo Therapeutics, Inc Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
29 transactions
Others Institutions Holding SGMO
# of Institutions
123Shares Held
55MCall Options Held
1.12MPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA11.6MShares$5.92 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.08MShares$4.12 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.84MShares$3.49 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.4 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X03.66MShares$1.87 Million0.21% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $79.8M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...